System and method for cell levitation and monitoring
US-2024361343-A1 · Oct 31, 2024 · US
US10369200B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10369200-B2 |
| Application number | US-201615252032-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 30, 2016 |
| Priority date | Jan 17, 2014 |
| Publication date | Aug 6, 2019 |
| Grant date | Aug 6, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and systems for releasing growth factors are disclosed. In certain embodiments, a blood sample is exposed to a sequence of one or more electric pulses to trigger release of a growth factor in the sample. In certain embodiments, the growth factor release is not accompanied by clotting within the blood sample.
Opening claim text (preview).
The invention claimed is: 1. A method for releasing growth factors, comprising: exposing a blood sample to a sequence of one or more electric pulses that trigger release of a growth factor in the blood sample, wherein the growth factor release is not accompanied by clotting within the blood sample. 2. The method of claim 1 , comprising: collecting the growth factor; and treating a patient with the growth factor, wherein the blood sample was acquired from the patient. 3. The method of claim 1 , wherein calcium ions are not added to the blood sample prior to exposing the blood sample to the sequence of one or more electric pulses. 4. The method of claim 1 , wherein the method comprises increasing calcium ion concentration and adding an ADP blocking agent to the blood sample prior to exposing the blood sample to the sequence of one or more electric pulses. 5. The method of claim 4 , wherein the ADP blocking chemical comprises apyrase. 6. The method of claim 1 , wherein the one or more electric pulses have an electric field strength between about 0.1 kV/cm and about 350 kV/cm. 7. The method of claim 1 , wherein the one or more electric pulses have pulse durations between about 1 nanosecond and about 100 microseconds. 8. The method of claim 1 , wherein the growth factor comprises platelet derived growth factor. 9. The method of claim 1 , wherein the blood sample is a whole blood sample or a platelet rich plasma.
of liquid biological material · CPC title
Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents · CPC title
Platelets; Megacaryocytes · CPC title
Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title
by electrical means (G01N33/49, G01N33/493 take precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.